维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="MARKERT JM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Bilateral metastatic renal hemangiopericytoma ten years 'after primary intracranial te- sion 显示文摘	Hammontrec LN Whilehead K Markert JM	2006	Int Braz J Urol2006，32，3：	1
2	Bilateral metastatic renal hemangiopericytoma ten years after primary intracranial lesion显示文摘	Hammontree LN Whitehead K Markert JM	2006	Int Braz J Urol2006，32，3：	1
3	Differential gene expression profiling in human brain tumors显示文摘	Markert JM Fuller CM Gillesp ie GY	2001	Physiol Genomics2001，5，1：	1
4	Experimental therapy of human glioma by means of a genetically engineered virus mutant 显示文摘	Martuza RL Malick A Markert JM ct al	1991	Science1991，252，5007：	1
5	Differential gene expression profiling in human brain tumors显示文摘	Fuller CM Gillespie GY	2001	Physiol Genomics2001，5，1：	1
6	Conditionally replicating herpes simplex virus mutant,G207 for the treatment of malignant glioma :results of a phase I trial显示文摘	Markert JM Medlock MD Rabkin SD	2000	Gene Ther2000，7，10：	1
7	Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection 显示文摘	MOORE TA 2nd MARKERT JM KNOWLTON RC	2006	Anesth analg2006，102，5：	1
8	Dexmede-tomidine as rescue drug during awake craniotomy forcortical motor mapping and tumor resection显示文摘	Markert TA 2nd Knowlton JM Knowlton RC	2006	Anesth Analg2006，102，5：	1
9	Experimental therapy of human glioma by means of a genetically engineered virus mutant显示文摘	Malick A Markert JM	1991	Science1991，252，：	1
10	Phase Ⅰ b trial of mutant herpes simplex virus G207 inoculated pre-and posttumor resection for recurrent GBM显示文摘	Markert JM Liechty PG Wang W	2009	Mol Ther2009，17，1：	1
11	Oncolytic HSV - 1 for the treatment of brain tumours 显示文摘	Markert JM Parker JN Buchsbaum D J	2006	Herpes2006，13，3：	1
12	Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection显示文摘	Moore TA 2nd Markert JM Knowlton RC	2006	Anesth analg2006，102，5：	1
13	Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria显示文摘	Pearson BE Markert JM Fisher WS	2008	Neurosurg Focus2008，24，：	1
14	Conditionally repl- icating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial 显示文摘	Markert JM Medlock MD Rabkin SD	2000	Gene Ther2000，7，：	1
15	Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM 显示文摘	Markert JM Liechty PG Wang W	2009	Mol Ther2009，17，：	1
16	Dexmedetomi- dine as Rescue Drug During Awake Craniotomy for Cortical Motor Mapping and Tumor Resection 显示文摘	Moore TA 2nd Markert JM Knowlton RC	2006	Anesth Analg2006，102，5：	1
17	Oncolytic HSV-1 for the treatment of brain turnouts 显示文摘	Markert JM Parker JN Buchsbaum DJ	2006	Herpes2006，13，3：	1
18	Conditionally replicating herpes simplex virus mutant,G207 for the treatment of malignant glioma:resuhs of a phase I trial 显示文摘	Markert JM Medlock MD Rabkin SD	2000	Gene Therapy2000，7，10：	1
19	Dexmedetomidine asrescue drug during awake craniotomy for cortical motor mappingand tumor resection显示文摘	Moore TA Markert JM Knowlton RC	2006	Anesth Analg2006，103，6：	1
20	Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection 显示文摘	Moore TA Markert JM Knowlton RC	2006	Anesth Analg2006，102，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示